Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy

NCT02098525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2014-03-28

No results posted yet for this study

Summary

Cryptococcal meningitis is one of the most common central nervous system infections among HIV-infected patients. The outcome is generally severe. This study aims to determine long-term survival rate among HIV-infected CM patients in the era of antiretroviral therapy (ART). The secondary objectives are to clarify outcomes of CM and determine prognostic factors.

Conditions

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Taiichiro Kobayashi, Dr · Mahidol University

  • Punnee Pitisuttithum, Prof. · Mahidol University

  • Weerawat Manosuthi, Dr. · Bamrasnaradura infectious disease hospital

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2013-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02098525 on ClinicalTrials.gov